1. Home
  2. AMCI vs TVGN Comparison

AMCI vs TVGN Comparison

Compare AMCI & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Robotics Corporation Common Stock

AMCI

AMC Robotics Corporation Common Stock

N/A

Current Price

$0.82

Market Cap

26.3M

Sector

Finance

ML Signal

N/A

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$5.69

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AMCI
TVGN
Founded
2021
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Blank Checks
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
21.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
AMCI
TVGN
Price
$0.82
$5.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 130.9K
7.8K
Earning Date
11-16-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $5,980,847.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.78
$0.14
52 Week High
$15.75
$24.91

Technical Indicators

Market Signals
Indicator
AMCI
TVGN
Relative Strength Index (RSI) 27.43 51.15
Support Level N/A $6.15
Resistance Level $3.99 $7.22
Average True Range (ATR) 0.28 0.40
MACD -0.01 0.08
Stochastic Oscillator 1.16 63.98

Price Performance

Historical Comparison
AMCI
TVGN

About AMCI AMC Robotics Corporation Common Stock

AMC Robotics Corp is a technology solutions company that offers AI-powered smart security and robotics solutions. It currently sells smart hardware products designed for residential and commercial use, including smart cameras, driving recorders, action cameras, and Retina K cameras, which are marketed under the YI brand. AMC Robotics is also engaged in developing additional hardware products and technology capabilities, including IoT-enabled devices, AI-based features, wearable devices, and AI robotics. Using its technological capabilities, the company is developing robotic dogs, robotic arms, and robotic unloading systems, offering smart solutions for the logistics and warehousing sectors. It has two primary operating segments: North America, which generates maximum revenue, and Europe.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: